PubRank

Z M Ruggeri

Author PubWeight™ 198.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996 5.12
2 Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 2006 4.58
3 Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell 1998 4.18
4 Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci U S A 2001 3.07
5 Platelets have more than one binding site for von Willebrand factor. J Clin Invest 1983 2.89
6 Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets. J Clin Invest 1980 2.88
7 The complex multimeric composition of factor VIII/von Willebrand factor. Blood 1981 2.76
8 Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells. J Virol 1996 2.38
9 Affinity modulation of the alpha IIb beta 3 integrin (platelet GPIIb-IIIa) is an intrinsic property of the receptor. Cell Regul 1990 2.29
10 Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proc Natl Acad Sci U S A 1990 2.23
11 Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease. N Engl J Med 1980 2.07
12 1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases. Lancet 1977 2.06
13 Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins. Blood 2000 2.05
14 Glanzmann thrombasthenia: deficient binding of von Willebrand factor to thrombin-stimulated platelets. Proc Natl Acad Sci U S A 1982 2.02
15 Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome. Proc Natl Acad Sci U S A 2000 1.94
16 Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell 1989 1.92
17 Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes. Blood 1982 1.86
18 Amino acid sequence of the von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. Proc Natl Acad Sci U S A 1987 1.73
19 von Willebrand factor. A reduced and alkylated 52/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib. J Biol Chem 1986 1.71
20 Modulation of platelet function through adhesion receptors. A dual role for glycoprotein IIb-IIIa (integrin alpha IIb beta 3) mediated by fibrinogen and glycoprotein Ib-von Willebrand factor. J Biol Chem 1992 1.70
21 Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III. J Biol Chem 1987 1.63
22 The von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. Characterization by monoclonal antibodies and partial amino acid sequence analysis of proteolytic fragments. J Biol Chem 1986 1.62
23 Role of beta3 integrins in melanoma cell adhesion to activated platelets under flow. J Biol Chem 1996 1.57
24 Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE). J Clin Invest 1986 1.51
25 Nucleotide polymorphisms in the alpha2 gene define multiple alleles that are associated with differences in platelet alpha2 beta1 density. Blood 1998 1.51
26 Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosis. Circulation 2000 1.48
27 Selective recognition of adhesive sites in surface-bound fibrinogen by glycoprotein IIb-IIIa on nonactivated platelets. J Biol Chem 1991 1.48
28 Enhanced botrocetin-induced type IIB von Willebrand factor binding to platelet glycoprotein Ib initiates hyperagglutination of normal platelets. Am J Hematol 1990 1.46
29 Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation. Relationship to the binding of fibrinogen and platelet aggregation. Blood 1987 1.46
30 Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation. J Clin Invest 1985 1.44
31 Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit. J Clin Invest 1991 1.41
32 Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J Clin Invest 1998 1.40
33 Structure of the von Willebrand factor domain interacting with glycoprotein Ib. J Biol Chem 1988 1.35
34 Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate. J Clin Invest 1989 1.33
35 Conformational changes in fibrinogen elicited by its interaction with platelet membrane glycoprotein GPIIb-IIIa. J Biol Chem 1993 1.29
36 Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis. J Thromb Haemost 2006 1.28
37 von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia. J Clin Invest 1986 1.28
38 Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets. J Biol Chem 1995 1.27
39 Asymptomatic liver disease in haemophiliacs. J Clin Pathol 1975 1.26
40 Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets. Blood 1993 1.25
41 Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody. J Clin Invest 1985 1.23
42 Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC). J Clin Invest 1982 1.23
43 Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation. Proc Natl Acad Sci U S A 1985 1.23
44 Crystal structure of the von Willebrand factor A1 domain in complex with the function blocking NMC-4 Fab. Nat Struct Biol 1998 1.22
45 Interaction of integrins alpha v beta 3 and glycoprotein IIb-IIIa with fibrinogen. Differential peptide recognition accounts for distinct binding sites. J Biol Chem 1990 1.21
46 Isolation of the von Willebrand factor domain interacting with platelet glycoprotein Ib, heparin, and collagen and characterization of its three distinct functional sites. J Biol Chem 1989 1.17
47 A heparin-binding domain of human von Willebrand factor. Characterization and localization to a tryptic fragment extending from amino acid residue Val-449 to Lys-728. J Biol Chem 1987 1.14
48 von Willebrand factor conformation and adhesive function is modulated by an internalized water molecule. Nat Struct Biol 2000 1.14
49 Regulation of von Willebrand factor binding to the platelet glycoprotein Ib-IX by a membrane skeleton-dependent inside-out signal. J Biol Chem 2001 1.14
50 Identification of a site in the alpha chain of platelet glycoprotein Ib that participates in von Willebrand factor binding. J Biol Chem 1990 1.13
51 Influence of fibrillar collagen structure on the mechanisms of platelet thrombus formation under flow. Blood 1999 1.13
52 Immunoradiometric assay of factor VIII related antigen, with observations in 32 patients with von Willebrand's disease. Br J Haematol 1976 1.12
53 Factor VIII-related properties in platelets from patients with von Willebrand's disease. J Lab Clin Med 1978 1.12
54 Isolation and functional characterization of the von Willebrand factor-binding domain located between residues His1-Arg293 of the alpha-chain of glycoprotein Ib. J Biol Chem 1988 1.11
55 A molecular model of RGD ligands. Antibody D gene segments that direct specificity for the integrin alpha IIb beta 3. J Biol Chem 1992 1.11
56 DDAVP enhances platelet adherence and platelet aggregate growth on human artery subendothelium. Blood 1984 1.10
57 Factor VIII/von Willebrand factor. Prog Hematol 1983 1.09
58 Identification of three tyrosine residues of glycoprotein Ib alpha with distinct roles in von Willebrand factor and alpha-thrombin binding. J Biol Chem 1995 1.08
59 Distinct structural attributes regulating von Willebrand factor A1 domain interaction with platelet glycoprotein Ibalpha under flow. J Biol Chem 1999 1.07
60 Epitope mapping of the von Willebrand factor subunit distinguishes fragments present in normal and type IIA von Willebrand disease from those generated by plasmin. J Clin Invest 1987 1.07
61 Distinct biological consequences of integrin alpha v beta 3-mediated melanoma cell adhesion to fibrinogen and its plasmic fragments. J Biol Chem 1992 1.06
62 Factor VIII and chronic renal failure. Br Med J 1977 1.06
63 Identification of a point mutation in type IIB von Willebrand disease illustrating the regulation of von Willebrand factor affinity for the platelet membrane glycoprotein Ib-IX receptor. Proc Natl Acad Sci U S A 1991 1.04
64 Elevated platelet count as a cause of abnormal von Willebrand factor multimer distribution in plasma. Blood 1993 1.04
65 Nonsense mutation in the glycoprotein Ib alpha coding sequence associated with Bernard-Soulier syndrome. Proc Natl Acad Sci U S A 1990 1.04
66 Homozygous and heterozygous deletions of the von Willebrand factor gene in patients and carriers of severe von Willebrand disease. Proc Natl Acad Sci U S A 1988 1.04
67 Isolation and characterization of a collagen binding domain in human von Willebrand factor. J Biol Chem 1986 1.03
68 Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon. J Clin Invest 1988 1.03
69 Increased thrombogenesis and embolus formation in mice lacking glycoprotein V. Blood 2001 1.02
70 Mechanisms of platelet aggregation. Curr Opin Hematol 2001 1.02
71 Factor VIII antigen in the vessel walls in von Willebrand's disease and haemophilia A. Scand J Haematol 1974 1.02
72 Proteolytic degradation of von Willebrand factor after DDAVP administration in normal individuals. Blood 1987 1.02
73 Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors. J Clin Invest 1987 1.01
74 von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease. J Clin Invest 1983 1.01
75 Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets. Proc Natl Acad Sci U S A 1986 1.01
76 Localization and characterization of an alpha-thrombin-binding site on platelet glycoprotein Ib alpha. J Biol Chem 1994 1.01
77 Von Willebrand factor promotes endothelial cell adhesion via an Arg-Gly-Asp-dependent mechanism. J Cell Biol 1989 1.00
78 Expression of human platelet glycoprotein Ib alpha in transgenic mice. J Biol Chem 1993 0.99
79 Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes. Thromb Haemost 1990 0.99
80 Function of glycoprotein Ib alpha in platelet activation induced by alpha-thrombin. J Biol Chem 1991 0.98
81 Point mutation in a leucine-rich repeat of platelet glycoprotein Ib alpha resulting in the Bernard-Soulier syndrome. J Clin Invest 1993 0.98
82 Multimeric structure of platelet factor VIII/von Willebrand factor: the presence of larger multimers and their reassociation with thrombin-stimulated platelets. Blood 1982 0.98
83 Type IIB von Willebrand's disease: differential clearance of endogenous versus transfused large multimer von willebrand factor. Blood 1982 0.97
84 Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation. J Clin Invest 1984 0.96
85 von Willebrand's Disease. Clin Haematol 1983 0.96
86 Von Willebrand's disease. Prog Hemost Thromb 1982 0.96
87 Type IIB Tampa: a variant of von Willebrand disease with chronic thrombocytopenia, circulating platelet aggregates, and spontaneous platelet aggregation. Blood 1985 0.96
88 Isoelectric focusing of human von Willebrand factor in urea-agarose gels. Blood 1983 0.96
89 The heterogeneity of type IIA von Willebrand's disease: studies with protease inhibitors. Blood 1986 0.94
90 Disulfide bond requirements for assembly of the platelet glycoprotein Ib-binding domain of von Willebrand factor. J Biol Chem 1993 0.94
91 Enhanced shear-induced platelet aggregation in acute myocardial infarction. Circulation 1999 0.93
92 Site-directed mutagenesis of a soluble recombinant fragment of platelet glycoprotein Ib alpha demonstrating negatively charged residues involved in von Willebrand factor binding. J Biol Chem 1991 0.93
93 The platelet glycoprotein Ib-IX complex. Prog Hemost Thromb 1991 0.93
94 Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin. A model for the regulation of von Willebrand factor binding to platelet glycoprotein Ib. J Biol Chem 1991 0.91
95 Characterization of the initial alpha-thrombin interaction with glycoprotein Ib alpha in relation to platelet activation. J Biol Chem 1998 0.91
96 Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease. Blood 2001 0.91
97 Adhesive properties of the isolated amino-terminal domain of platelet glycoprotein Ibalpha in a flow field. Proc Natl Acad Sci U S A 1999 0.91
98 Conformational changes in the A1 domain of von Willebrand factor modulating the interaction with platelet glycoprotein Ibalpha. J Biol Chem 1996 0.91
99 The activation state of the integrin alpha IIb beta 3 affects outside-in signals leading to cell spreading and focal adhesion kinase phosphorylation. J Biol Chem 1995 0.91
100 Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa. J Clin Invest 1990 0.91
101 Generation and characterization of peptide-specific antibodies that inhibit von Willebrand factor binding to glycoprotein IIb-IIIa without interacting with other adhesive molecules. Selectivity is conferred by Pro1743 and other amino acid residues adjacent to the sequence Arg1744-Gly1745-Asp1746. J Biol Chem 1988 0.91
102 Variable effect of P2Y12 inhibition on platelet thrombus volume in flowing blood. J Thromb Haemost 2011 0.90
103 Binding of the snake venom-derived proteins applaggin and echistatin to the arginine-glycine-aspartic acid recognition site(s) on platelet glycoprotein IIb.IIIa complex inhibits receptor function. J Biol Chem 1990 0.90
104 Isolation and chemical characterization of two structurally and functionally distinct forms of botrocetin, the platelet coagglutinin isolated from the venom of Bothrops jararaca. Biochemistry 1991 0.90
105 Variant Bernard-Soulier syndrome type bolzano. A congenital bleeding disorder due to a structural and functional abnormality of the platelet glycoprotein Ib-IX complex. J Clin Invest 1990 0.90
106 Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib. J Biol Chem 2001 0.90
107 Different effects of various anti-GPIIb-IIIa agents on shear-induced platelet activation and expression of procoagulant activity. J Thromb Haemost 2003 0.89
108 Independent assembly and secretion of a dimeric adhesive domain of von Willebrand factor containing the glycoprotein Ib-binding site. J Biol Chem 1991 0.89
109 The effect of DDAVP on plasma levels of von Willebrand antigen II in normal individuals and patients with von Willebrand's disease. Blood 1984 0.89
110 Letter: Pathogenesis of von Willebrand's disease. Lancet 1976 0.89
111 Subunit composition of plasma von Willebrand factor in patients with the myeloproliferative syndrome. Blood 1986 0.89
112 Contributions of thrombin targets to tissue factor-dependent metastasis in hyperthrombotic mice. J Thromb Haemost 2014 0.88
113 Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection. Arterioscler Thromb 1992 0.88
114 Interaction of integrin alpha IIb beta 3 with multiple fibrinogen domains during platelet adhesion. J Biol Chem 1995 0.88
115 Studies on the prolonged bleeding time in von Willebrand's disease. J Lab Clin Med 1976 0.88
116 Expression of the phenotypic abnormality of platelet-type von Willebrand disease in a recombinant glycoprotein Ib alpha fragment. J Clin Invest 1993 0.88
117 D.D.A.V.P. in haemophilia. Lancet 1977 0.87
118 A role for von Willebrand factor proline residues 702-704 in ristocetin-mediated binding to platelet glycoprotein Ib. Thromb Haemost 1993 0.87
119 A type 2b von Willebrand disease mutation (Ile546-->Val) associated with an unusual phenotype. Thromb Haemost 1997 0.87
120 Further characterization of platelet-type von Willebrand's disease in Japan. Blood 1984 0.87
121 Correlation between circulating levels of von Willebrand's antigen II and von Willebrand factor: discrimination between type I and type II von Willebrand's disease. J Lab Clin Med 1984 0.87
122 Defective dimerization of von Willebrand factor subunits due to a Cys-> Arg mutation in type IID von Willebrand disease. Proc Natl Acad Sci U S A 1996 0.87
123 Familial incidence of precipitating antibodies in von Willebrand's disease: a study of four cases. J Lab Clin Med 1979 0.86
124 Precipitating antibodies in von Willebrand's disease. Nature 1976 0.86
125 Cloning of the murine platelet glycoprotein Ibalpha gene highlighting species-specific platelet adhesion. Blood Cells Mol Dis 1997 0.86
126 von Willebrand disease type IIC with different abnormalities of von Willebrand factor in the same sibship. Am J Hematol 1986 0.86
127 Alterations in fibrinolysis and blood coagulation. Lancet 1969 0.85
128 Platelets and von Willebrand disease. Semin Hematol 1985 0.85
129 Classification of variant von Willebrand's disease subtypes by analysis of functional characteristics and multimeric composition of factor VIII/von Willebrand factor. Ann N Y Acad Sci 1981 0.85
130 von Willebrand disease. Hum Pathol 1987 0.85
131 The von willebrand factor domain-mediating botrocetin-induced binding to glycoprotein IB lies between Val449 and Lys728. Blood 1987 0.85
132 Cell adhesion in vascular biology: series introductin. J Clin Invest 1996 0.85
133 Analysis of structure-function relationships in the platelet membrane glycoprotein Ib-binding domain of von Willebrand's factor by expression of deletion mutants. J Biol Chem 1993 0.84
134 Anti-idiotypic antibodies against an antibody to the platelet glycoprotein (GP) IIb-IIIa complex mimic GP IIb-IIIa by recognizing fibrinogen. J Biol Chem 1992 0.83
135 von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure. J Clin Invest 1993 0.83
136 Increased fragmentation of von Willebrand factor, due to abnormal cleavage of the subunit, parallels disease activity in recurrent hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and discloses predisposition in families. The Italian Registry of Familial and Recurrent HUS/TTP. Blood 1999 0.83
137 Receptor-specific antiplatelet therapy. Circulation 1989 0.82
138 Crystal structure of the von Willebrand factor modulator botrocetin. Biochemistry 2001 0.82
139 von Willebrand factor competes with fibrin for occupancy of GPIIb:IIIa on thrombin-stimulated platelets. Blood 1990 0.82
140 Immunological heterogeneity of haemophilia B: a multicentre study of 98 kindreds. Br J Haematol 1978 0.82
141 Proteolysis of von Willebrand factor in therapeutic plasma concentrates. Blood 1994 0.82
142 Fine mapping of monoclonal antibody epitopes on human von Willebrand factor using a recombinant peptide library. Thromb Haemost 1992 0.81
143 Functional modulation of the isolated glycoprotein Ib binding domain of von Willebrand factor expressed in Escherichia coli. Biochemistry 1991 0.81
144 Selective interaction of a conformationally-constrained Arg-Gly-Asp (RGD) motif with the integrin receptor alphavbeta3 expressed on human tumor cells. Blood Cells Mol Dis 1997 0.81
145 High-resolution analysis of von Willebrand factor multimeric composition defines a new variant of type I von Willebrand disease with aberrant structure but presence of all size multimers (type IC). Blood 1985 0.81
146 A new variant of type II von Willebrand disease with aberrant multimeric structure of plasma but not platelet von Willebrand factor (type IIF). Blood 1986 0.81
147 Genetic deletion of platelet glycoprotein Ib alpha but not its extracellular domain protects from atherosclerosis. Thromb Haemost 2014 0.80
148 Unique interactions of asialo von Willebrand factor with platelets in platelet-type von Willebrand disease. Blood 1987 0.80
149 Nervous regulation of factor-VIII levels in man. Br J Haematol 1971 0.80
150 Genetic and structural characterization of an amino acid dimorphism in glycoprotein Ib alpha involved in platelet transfusion refractoriness. Blood 1992 0.80
151 Spontaneous platelet aggregation in type IIB Tampa von Willebrand disease is inhibited by the 52/48-kDa fragment of normal von Willebrand factor, which contains the GPIb binding domain. Am J Hematol 1989 0.80
152 von Willebrand factor, now cloned. Br J Haematol 1986 0.80
153 Modeling and functional analysis of the interaction between von Willebrand factor A1 domain and glycoprotein Ibalpha. J Biol Chem 2000 0.79
154 Interruption of vascular thrombosis by bolus anti-platelet glycoprotein IIb/IIIa monoclonal antibodies in baboons. J Vasc Surg 1993 0.79
155 Hemophilia care in Italy. Thromb Haemost 1976 0.79
156 Letter: Clotting factors in von Willebrand's disease. Lancet 1974 0.79
157 Letter: Concentrates of clotting-factor IX. Lancet 1976 0.79
158 Heparin-associated thrombocytopenia: observations on the mechanism of platelet aggregation. J Lab Clin Med 1989 0.78
159 Evidence that the arg1744 gly1745 asp1746 sequence in the GPIIb-IIIa-binding domain of von Willebrand factor is involved in platelet adhesion and thrombus formation on subendothelium. J Lab Clin Med 1993 0.78
160 A new congenital platelet abnormality characterized by spontaneous platelet aggregation, enhanced von Willebrand factor platelet interaction, and the presence of all von Willebrand factor multimers in plasma. Blood 1989 0.78
161 A molecular approach to the classification of von Willebrand disease. Best Pract Res Clin Haematol 2001 0.77
162 Precipitating antibodies to factor VIII/von Willebrand factor in von Willebrand's disease: effects on replacement therapy. Blood 1981 0.77
163 Structure-function relationships of platelet glycoprotein Ib as a receptor for von Willebrand factor. Nihon Ketsueki Gakkai Zasshi 1986 0.77
164 Platelet aggregation on extracellular matrix: effect of a recombinant GPIb-binding fragment of von Willebrand factor. Thromb Haemost 1993 0.77
165 Separation of human megakaryocytes by state of differentiation on continuous gradients of Percoll: size and ploidy analysis of cells identified by monoclonal antibody to glycoprotein IIb/IIIa. Blood 1986 0.77
166 Synthetic peptides inhibit the interaction of von Willebrand factor-platelet membrane glycoproteins. Peptides 1993 0.77
167 Letter: Enhanced factor VIII activity in von Willebrand's disease. N Engl J Med 1974 0.77
168 Bernard-Soulier syndrome: quantitative characterization of megakaryocytes and platelets by flow cytometric and platelet kinetic measurements. Eur J Haematol 1994 0.76
169 Platelet collagen receptors and risk prediction in stroke and coronary artery disease. Circulation 2001 0.76
170 Reversible activation defect of the platelet glycoprotein IIb-IIIa complex in patients with uremia. Am J Kidney Dis 1993 0.75
171 Urinary excretion of factor VIII after renal transplantation. Br Med J 1979 0.75
172 Role of platelet adhesion and aggregation in antithrombotic therapy. West J Med 1993 0.75
173 Acquired abnormalities of von Willebrand factor: facts to consider in patients with unexpected bleeding. J Lab Clin Med 1993 0.75
174 [Further evaluation of GPIb binding domain of vWf by synthetic peptides]. Rinsho Byori 1992 0.75
175 Varied immunological reactivity of factor VIII from animal plasmas. Thromb Res 1980 0.75
176 [Factor VIII inhibitors]. Ric Clin Lab 1978 0.75
177 Differences between heterozygous dominant and recessive von Willebrand's disease type I expressed by bleeding symptoms and combinations of factor VIII variables. Thromb Haemost 1983 0.75
178 Secretion of von Willebrand factor from platelets. Methods Enzymol 1989 0.75
179 [Factor VIII and glomerular nephropathy]. Minerva Nefrol 1981 0.75
180 Proceedings: Mechanisms of the prolonged bleeding time in von Willebrand's disease (vWd). Thromb Diath Haemorrh 1975 0.75
181 Crystal structure of NMC-4 fab anti-von Willebrand factor A1 domain. Blood Cells Mol Dis 1997 0.75
182 1-Deamino-8-D-arginine vasopressin and cryoprecipitate in variant von Willebrand disease. Am J Hematol 1985 0.75
183 Multiple epitope specificity of monoclonal antibodies to a single synthetic peptide: use in the characterization of the GP IIb-IIIa binding domain of von Willebrand factor. Adv Exp Med Biol 1990 0.75
184 Heterogeneity in von Willebrand's disease. Prog Clin Biol Res 1981 0.75
185 Evaluation of the abnormal platelet function in von Willebrand disease by the blood filtration test. Thromb Haemost 1996 0.75
186 Urinary excretion of factor-VIII-related antigen and fibrin(ogen) degradation fragments D and E after kidney transplantation. Transplant Proc 1979 0.75
187 Two antipeptide monoclonal antibodies that recognize adhesive sequences in fibrinogen: identification of antigenic determinants and unrelated sequences using synthetic combinatorial libraries. Biomed Pept Proteins Nucleic Acids 1995 0.75
188 Circulating anticoagulants in haemophilia. Lancet 1970 0.75
189 Preliminary trial of cyclophosphamide in the management of hemophiliacs with factor VIII inhibitors. Ann N Y Acad Sci 1975 0.75
190 Effect of shear stress on fibrinogen adsorption and its conformational change. ASAIO J 1996 0.75
191 Factor VIII/von Willebrand factor in glomerular nephropathies. Clin Nephrol 1981 0.75
192 [Multimeric structure of factor VIII/von Willebrand factor released from human platelets by ADP, collagen and thrombin]. Sangre (Barc) 1983 0.75
193 Generation and characterization of specific antibodies directed to the binding domain of adhesive molecules. Pept Res 1992 0.75